PG
BMY icon

PEAK6 Group’s Bristol-Myers Squibb BMY Stock Holding History

PEAK6 Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$29.6M Buy
534,900
+113,400
+27% +$6.12M 0.13% 140
2018
Q1 		$26.7M Buy
421,500
+216,400
+106% +$13.9M 0.12% 157
2017
Q4 		$12.6M Buy
205,100
+18,000
+10% +$1.13M 0.06% 380
2017
Q3 		$11.9M Sell
187,100
-142,300
-43% -$8.31M 0.06% 343
2017
Q2 		$18.4M Sell
329,400
-45,300
-12% -$2.47M 0.11% 181
2017
Q1 		$20.4M Buy
374,700
+86,100
+30% +$4.72M 0.17% 120
2016
Q4 		$16.9M Sell
288,600
-11,200
-4% -$612K 0.12% 170
2016
Q3 		$16.2M Buy
299,800
+213,400
+247% +$13.7M 0.12% 183
2016
Q2 		$6.36M Buy
86,400
+6,000
+7% +$424K 0.05% 541
2016
Q1 		$5.14M Sell
80,400
-124,200
-61% -$7.83M 0.04% 596
2015
Q4 		$14.1M Buy
204,600
+20,200
+11% +$1.33M 0.09% 256
2015
Q3 		$10.9M Buy
184,400
+20,200
+12% +$1.28M 0.06% 431
2015
Q2 		$10.9M Buy
164,200
+42,200
+35% +$2.78M 0.07% 391
2015
Q1 		$7.87M Sell
122,000
-7,000
-5% -$438K 0.06% 431
2014
Q4 		$7.62M Buy
129,000
+22,100
+21% +$1.25M 0.06% 427
2014
Q3 		$5.47M Sell
106,900
-47,400
-31% -$2.37M 0.04% 605
2014
Q2 		$7.49M Buy
154,300
+117,000
+314% +$5.77M 0.07% 353
2014
Q1 		$1.94M Buy
37,300
+22,300
+149% +$1.19M 0.02% 1281
2013
Q4 		$798K Sell
15,000
-33,300
-69% -$1.7M 0.01% 2252
2013
Q3 		$2.24M Sell
48,300
-1,700
-3% -$74.6K 0.02% 1434
2013
Q2 		$2.23M Buy
+50,000
New +$2.17M 0.01% 1425

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PEAK6 Group's BMY Position: Q2 2018 in Review

PEAK6 Group increased its Bristol-Myers Squibb (BMY) stake by 66% in Q2 2018, buying an estimated $1.78M and bringing the position to 82,852 shares worth $4.58M. The position accounts for 0.02% of the portfolio, ranked #818.

PEAK6 Group first reported a position in BMY in Q3 2013 and has held it in 12 quarters since. The position peaked at $12.1M in Q4 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

  • PEAK6 Group held 82,852 shares of Bristol-Myers Squibb worth $4.58M as of Q2 2018.
  • PEAK6 Group bought 32,903 Bristol-Myers Squibb shares in Q2 2018, an estimated $1.78M.
  • Bristol-Myers Squibb made up 0.02% of PEAK6 Group's portfolio in Q2 2018, its #818 holding.
  • PEAK6 Group first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 12 quarters since.
  • PEAK6 Group's Bristol-Myers Squibb position peaked at $12.1M in Q4 2016.
  • 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.